Modified citrus pectin protects aortic dissection development involving macrophage pyroptosis
MCP could improve patient outcomes and reduce progression to severe forms of AD. Clinically, MCP could serve as supportive therapy to prevent and delay aortic dissection, particularly during the acute stage of uncomplicated type B AD in patients with Marfan syndrome or abdominal aortic aneurysm.
Authors
- Chun-Che Shih (ORCID: https://orcid.org/0000-0002-9116-7919)
- Fwu‐Long Mi (ORCID: https://orcid.org/0000-0001-8063-3358)
- C. Liu
- Chin‐Yu Lin (ORCID: https://orcid.org/0000-0003-3282-7523)
- Chi Lin (ORCID: https://orcid.org/0000-0002-7279-0473)
- Chih‐Pin Chuu (ORCID: https://orcid.org/0000-0001-7206-7923)
- Hsin‐Ying Lu (ORCID: https://orcid.org/0000-0002-9897-0923)
Institutions
- University of Arizona (US)
- National Health Research Institutes (TW)
- China Medical University (TW)
- Taipei Medical University Hospital (TW)
- Mackay Medical University (TW)
- Taichung Veterans General Hospital (TW)
- China Medical University Hospital (TW)
- Taipei Medical University (TW)
Publication Details
- Journal
- Archives of Biochemistry and Biophysics
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1016/j.abb.2025.110428
- Citations
- 1
- Primary Topic
- Galectins and Cancer Biology
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- Ministry of Science and Technology, Taiwan
- Taipei Medical University
- Wan Fang Hospital